Closed
SectorHealthcare
11.4 -1.55
24h
Min
11.24
Max
11.56
Income | -278M -252M |
---|---|
Sales | -1.4M 7.6M |
EPS | -0.218 |
Profit margin | -3,333.884 |
Employees | 750 |
EBITDA | -9.2M -284M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +31.58% upside |
Market Cap | 224M 7.8B |
---|---|
Previous open | 12.95 |
Previous close | 11.4 |
By Acuity
50%
50%
154 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 15 USD 31.58%
High 18 USD
Low 12 USD
Based on 7 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$